Attorney Advertising  ·  The Alvarez Law Firm  ·  Coral Gables, FL

LAWSUIT
Loop
See If You Qualify
Drug Shortage COPD / Lung Disease

Albuterol Inhalers Are in Short Supply — COPD Patients Need to Know This

The FDA has confirmed that albuterol sulfate inhalation solution — a rescue medication that millions of people with COPD and asthma depend on to breathe — is currently in short supply. If you or someone you care for has been having trouble filling this prescription, you are not alone, and there are steps you can take right now.

By Lawsuit Loop Staff · Published June 3, 2026 · 5 min read
Stock image — not an actual client or event
⚠ If You Are Having a Breathing Emergency

If you are having trouble breathing and cannot reach your inhaler or nebulizer medication, call 911 or go to the nearest emergency room immediately. Do not wait. A shortage at your pharmacy is never a reason to go without emergency care.

The short version: Albuterol sulfate inhalation solution — the liquid form of albuterol used in nebulizer machines — is currently listed as "in shortage" on the FDA's official drug shortages database. This form of the medication is especially common among older adults with COPD, people who have difficulty using a handheld inhaler, and those with more severe breathing problems. The shortage does not affect all forms of albuterol equally, but patients are reporting real trouble getting their prescriptions filled.

What Is Albuterol and Why Does the Shortage Matter

Albuterol is what doctors call a bronchodilator. It works by relaxing the muscles around the airways in your lungs, which allows those airways to open up and makes it easier to breathe. It is one of the most widely used medications in the United States and has been a standard rescue treatment for lung conditions for decades.

There are two main ways it is delivered: through a metered-dose inhaler — the hand-held pressurized canister most people picture when they think of an "inhaler" — and through an inhalation solution, which is a liquid that goes into a nebulizer machine and is breathed in as a fine mist over several minutes. The current FDA shortage specifically involves the inhalation solution.

For many patients, particularly older adults and those with more severe lung disease, the nebulizer is not just a preference — it is the only delivery method that works well for them. They may not have the hand strength or coordination to use a traditional inhaler effectively, or their breathing may be too weak to draw in a full dose. For those patients, a shortage of the inhalation solution is not a minor inconvenience. It is a gap in a medication they cannot safely go without.

Who Depends on It Most

COPD — chronic obstructive pulmonary disease — is a long-term lung condition that makes breathing progressively harder over time. According to the Centers for Disease Control and Prevention, about 16 million Americans have been diagnosed with COPD, and millions more may have the disease without knowing it. Asthma affects approximately 25 million Americans. Together, these two conditions account for the vast majority of albuterol prescriptions in the country.

For people with COPD in particular, albuterol is often used several times a day. During a flare-up — when the airways tighten and breathing becomes especially difficult — it can mean the difference between managing at home and ending up in the emergency room.

Here is something that does not always get said plainly enough: smoking is the leading cause of COPD. The American Lung Association estimates that cigarette smoking is responsible for as many as 85 to 90 percent of all COPD cases in the United States. If you have COPD, there is a very good chance that cigarette smoke — whether from your own smoking or from long-term secondhand exposure — played a major role in damaging your lungs.

"Cigarette smoking is the leading cause of COPD. About 85 to 90 percent of all COPD cases are caused by cigarette smoking." American Lung Association, COPD Causes and Risk Factors

What to Do If Your Pharmacy Doesn’t Have It

A drug shortage does not mean every pharmacy is out of stock at the same time. Supply can vary significantly by location, pharmacy chain, and which distributor they use. Here are the most useful steps you can take right now:

  • Call ahead before driving anywhere. Ask your pharmacy specifically whether they have albuterol sulfate inhalation solution in the concentration and unit size you use (0.083% solution in 3 mL unit-dose vials is the most common). Be specific about the form you need.
  • Try independent pharmacies. They sometimes source from different distributors than large chains like CVS or Walgreens and may have stock when others don't.
  • Ask your doctor about switching forms. If you currently use a nebulizer, your doctor may be able to prescribe a metered-dose inhaler with a spacer device, which can be an effective alternative for some patients. Do not make this switch on your own — ask your doctor first.
  • Check mail-order pharmacies. Your insurance plan may allow mail-order refills, which often source from different supply chains and may have availability.
  • Do not ration or skip doses without talking to your doctor. If you are running low, call your doctor before your medication runs out, not after.

Did Smoking Cause Your COPD?

If you smoked for years and now have COPD, emphysema, or chronic bronchitis, it is worth understanding why your lungs are in the condition they are in — and what your legal options might be.

For decades, tobacco companies publicly denied that their products caused serious disease. Internal documents that came to light through court cases showed that cigarette manufacturers knew about the health dangers of their products — including the damage to the lungs that causes COPD — but chose not to tell the public. They ran advertising campaigns designed to cast doubt on the science, and they engineered their products to make them more addictive.

Courts have found these companies liable for the harm they caused to smokers. If you developed COPD, emphysema, lung disease, or other serious conditions from smoking, you may have the right to seek help through the legal system. This is true even if you started smoking a long time ago, and even if you have since quit.

You can read more about how these cases work on our tobacco lawsuit page. Cases are handled on a contingency basis, which means you pay nothing upfront — a lawyer only gets paid if you do.

When to Talk to a Lawyer

If you have COPD, lung disease, or another serious health condition that you believe was caused by years of cigarette smoking, it may be worth having a free conversation with a lawyer who handles these cases. You do not need to have a specific product recall or a clear-cut case already figured out. You just need to describe what happened to you and let someone who knows this area of law tell you whether your situation qualifies.

A few situations where it makes particular sense to ask:

  • You smoked for 10 or more years and have been diagnosed with COPD, emphysema, chronic bronchitis, or lung cancer
  • You began smoking as a teenager or young adult, before you fully understood the risks
  • Your health has gotten significantly worse in recent years and it affects your daily life
  • You have had hospitalizations, oxygen therapy, or major medical expenses related to your lung condition

Use the button below to share a few details about your situation. There is no cost, no pressure, and no commitment required to find out whether you qualify.

See If You Qualify →

Sources

  1. U.S. Food and Drug Administration. "Drug Shortages: Albuterol Sulfate." accessdata.fda.gov/scripts/drugshortages/default.cfm. Accessed June 2026.
  2. Centers for Disease Control and Prevention. "Chronic Obstructive Pulmonary Disease (COPD) — Data and Statistics." cdc.gov/copd. Accessed June 2026.
  3. American Lung Association. "COPD Causes and Risk Factors." lung.org. Accessed June 2026.
  4. Centers for Disease Control and Prevention. "Current Cigarette Smoking Among Adults in the United States." cdc.gov/tobacco. Accessed June 2026.
  5. Global Initiative for Chronic Obstructive Lung Disease (GOLD). "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease." 2025 Report. goldcopd.org.
  6. National Heart, Lung, and Blood Institute. "COPD Treatment." nhlbi.nih.gov. Accessed June 2026.

More Consumer News

See If You Qualify